Show events:

Search

The 2nd Asia Pacific Symposium on Diabetes, Hypertension, Metabolic Syndrome and Pregnancy - DIPAP Greater China

Date: 16. - 18.03.2018
Time: 08:00 h - 18:00 h

The DIP Symposium continuously aims to lead a greater global focus on Hypertension in Pregnancy (HIP), maternal and fetal medicine. Doing so by raising awareness of the links between hyperglycemia and poor maternal and fetal outcomes as well as to the future health risks to mother and offspring and demand a clearly defined global health agenda to tackle this issue. To provide guidance for testing, management and care of women with HIP regardless of resource setting as outlined in the FIGO document and to inspire action by showcasing ongoing initiatives on diabetes in pregnancy in the region and globally.

The DIPAP Greater China Symposium will introduce a unique program on “Digital Health” whereby start-up companies, innovative concepts, development of ideas to execution will be brought to the forefront in keynote lectures and demonstrations. A never-before collaboration of Scientific content and hi-tech will meet, listen and discuss on the third day of the Symposium. The Digital Health program will successfully address and highlight the importance of introducing and including digital health within the treatment of Diabetes, Hypertension, Metabolic Syndrome and Pregnancy.

Medical topics:

Diabetology

Host

ComtecMed
Go to address

Venue:

Jing An Shangri La West Shanghai
1218 Middle Yan'an Road
CN 200040 Shanghai
Go to map

Booking information

Show hotels near the venue

Recommend this event via e-mail

Host:

ComtecMed
53 Rotcshild
IL 61000 Tel Aviv
Phone: 972.3.566.6166
E-mail: tamar@comtecmed.com

No data available yet

No data available yet

Venue:

Jing An Shangri La West Shanghai
1218 Middle Yan'an Road
CN 200040 Shanghai


View larger map

Rating
Further Information

Frequency: annually

Exhibition: Yes

Special topics:
The Non Communicable Disease & Pregnancy global epidemic - It’s all about the mother and the offspring The Non Communicable Disease & Pregnancy – The FIGO Global vision The IDF Global Vision: Diabetes in Pregnancy Maternal Health – The Impact of Diabetes, Obesity, Hypertension in Pregnancy The Mother with Pregnancy Induced Complications – How do we Improve Outcome? The Fetus - Is There an Optimal Birth Weight? The Fetus - Prevention of Preterm Birth: Towards Healthy Mothers and Healthy Babies Renovating Maternal Fetal Medicine Maternal Fetal Medicine - The Great Obstetrical Syndromes; from basics to molecular biology Fetal Medicine - Innovations in prediction and prevention New technologies in diabetic pregnancy Placental insufficiency: preeclampsia and fetal growth The pathogenesis of preeclampsia: Clues to prevention and treatment Preeclampsia: identification of pre-clinical disease and management issues Early prediction and prevention of IUGR IUGR and SGA: Doppler management and prediction of outcomeObesity or Metabolic Syndrome in Pregnancy, which is more hazardous to the mother and offspring? Perinatal programming of obesity Pre-pregnancy management of the obese patient Health system and societal barriers in improving diabetes related maternal health Towards a Consensus; The FIGO-GDM Initiative Project The Asia Pacific Experience: Learning from the SAIDIP & Greater China experience Tribulations and triumphs in implementing a national strategy for GDM screening diagnosis and care in India Analysis of the cost-effectiveness of carrying out GDM screening in India Gestational diabetes mellitus in China: Difficulties and coping strategies Analysis of the cost-effectiveness of carrying out GDM screening in China State of the art on insulin analogues and pregnancy Differences between early and late onset placental disease - implications for screening Aspects of preeclampsia risk calculation: Populations and individuals First-trimester maternal risk assessment - A health economic perspective Critical evaluation of potential treatments: The case for/against aspirin Towards a solution - The ASPRE Study Nutritional factors and supplementation on maternal and infant outcome Diet and pregnancy outcomes- examples based on the role of micronutrients and macronurients in the development of gestational diabetes Nutritional supplementation and the prevention of fetal congenital abnormalitie Differences in growth trajectories between infants of women with type-1 and type-2 diabetes?

Congress President:
Moshe Hod, Israel | Tony Duan, China Gian Carlo Di Renzo, Italy | Guang Ning, China | Luis Cabero Roura, Spain
dipmarketing@comtecmed.com
http://www.comtecmed.com/dipap/2018/

Tags/key words:
diabetes, hypertension, metabolic syndrome, pregnancy

HRS.de